HOXB4 and neutropenia: In conclusion, our results demonstrate that HOXB4-mediated expansion of CD34+ cells leads to a significantly improved engraftment of short-term repopulation cells with the potential to prevent severe neutropenia after myeloablative HSC transplantation.